Javascript must be enabled to continue!
Identification of MLL partner genes in 27 patients with acute leukemia from a single cytogenetic laboratory
View through CrossRef
Chromosomal rearrangements involving the MLL gene have been associated with many different types of hematological malignancies. Fluorescent in situ hybridization with a panel of probes coupled with long distance inverse‐PCR was used to identify chromosomal rearrangements involving the MLL gene. Between 1995 and 2010, 27 patients with an acute leukemia were found to have a fusion gene involving MLL. All seven ALL patients with B cell acute lymphoblastic leukemia were characterized by the MLL/AFF1 fusion gene resulting from a translocation (5 patients) or an insertion (2 patients). In the 19 AML patients with acute myeloblastic leukemia, 31.6% of all characterized MLL fusion genes were MLL/MLLT3, 21.1% MLL/ELL, 10.5% MLL/MLLT6 and 10.5% MLL/EPS15. Two patients had rare or undescribed fusion genes, MLL/KIAA0284 and MLL/FLNA. Seven patients (26%) had a complex chromosomal rearrangement (three‐way translocations, insertions, deletions) involving the MLL gene. Splicing fusion genes were found in three patients, leading to a MLL/EPS15 fusion in two and a MLL/ELL fusion in a third patient. This study showed that fusion involving the MLL gene can be generated through various chromosomal rearrangements such as translocations, insertions and deletions, some being complex or cryptic. A systematic approach should be used in all cases of acute leukemia starting with FISH analyses using a commercially available MLL split signal probe. Then, the analysis has to be completed, if necessary, by further molecular cytogenetic and genomic PCR methods.
Title: Identification of MLL partner genes in 27 patients with acute leukemia from a single cytogenetic laboratory
Description:
Chromosomal rearrangements involving the MLL gene have been associated with many different types of hematological malignancies.
Fluorescent in situ hybridization with a panel of probes coupled with long distance inverse‐PCR was used to identify chromosomal rearrangements involving the MLL gene.
Between 1995 and 2010, 27 patients with an acute leukemia were found to have a fusion gene involving MLL.
All seven ALL patients with B cell acute lymphoblastic leukemia were characterized by the MLL/AFF1 fusion gene resulting from a translocation (5 patients) or an insertion (2 patients).
In the 19 AML patients with acute myeloblastic leukemia, 31.
6% of all characterized MLL fusion genes were MLL/MLLT3, 21.
1% MLL/ELL, 10.
5% MLL/MLLT6 and 10.
5% MLL/EPS15.
Two patients had rare or undescribed fusion genes, MLL/KIAA0284 and MLL/FLNA.
Seven patients (26%) had a complex chromosomal rearrangement (three‐way translocations, insertions, deletions) involving the MLL gene.
Splicing fusion genes were found in three patients, leading to a MLL/EPS15 fusion in two and a MLL/ELL fusion in a third patient.
This study showed that fusion involving the MLL gene can be generated through various chromosomal rearrangements such as translocations, insertions and deletions, some being complex or cryptic.
A systematic approach should be used in all cases of acute leukemia starting with FISH analyses using a commercially available MLL split signal probe.
Then, the analysis has to be completed, if necessary, by further molecular cytogenetic and genomic PCR methods.
Related Results
Abstract B35: Estradiol drives MLL gene fusions in infant acute leukemia
Abstract B35: Estradiol drives MLL gene fusions in infant acute leukemia
Abstract
Translocation breakpoints involving the MLL gene linked to Infant Acute Leukemia (IAL) and therapy related acute leukemia (tAL) are tightly clustered betwee...
Abstract 4345: Epigenetic dysregulation of transcriptional program in MLL-EEN leukemia
Abstract 4345: Epigenetic dysregulation of transcriptional program in MLL-EEN leukemia
Abstract
Aberrant DNA methylation is a typical feature of cancers, which is usually associated with deregulation of tumor suppressor genes and oncogenes. Mixed linea...
PRMT1 Activates Leukemic Stem Cell Program in MLL-Rearranged Leukemia
PRMT1 Activates Leukemic Stem Cell Program in MLL-Rearranged Leukemia
Abstract
In MLL-rearranged leukemia, the Mixed Lineage Leukemia (MLL) gene undergoes chromosomal translocation that results in the loss of C-terminal histone methylt...
The Role of MLL1 and MLL2 in MLL Fusion Oncoprotein-Initiated Leukemia
The Role of MLL1 and MLL2 in MLL Fusion Oncoprotein-Initiated Leukemia
Abstract
The MLL1 histone methyltransferase gene at 11q23 undergoes many distinct chromosomal translocations to yield poor prognosis leukemia. In these MLL-rearrange...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Novel Spliced MLL Fusions Have Been Identified Involving the MLL Partner Genes ELL, EPS15, MLLT3, and SEPT5.
Novel Spliced MLL Fusions Have Been Identified Involving the MLL Partner Genes ELL, EPS15, MLLT3, and SEPT5.
Abstract
Chromosomal rearrangements of the human MLL gene are a genetic hallmark for aggressive acute leukemias. More than 60 partner genes have been characterized a...
MLL-Aberrations, Associated to T-AML, Are Induced by Chemotherapy In Vivo.
MLL-Aberrations, Associated to T-AML, Are Induced by Chemotherapy In Vivo.
Abstract
Background: Therapy related acute myelogenous leukemias (t-AML) are frequently observed following previous chemotherapy with alkylating agents and topoisome...
Flt3 Is Required for MLL-ENL-Induced Leukemogenesis In Vivo, but Not for LSC Function in Vitro
Flt3 Is Required for MLL-ENL-Induced Leukemogenesis In Vivo, but Not for LSC Function in Vitro
Abstract
Abstract 2450
Flt3 is a type III tyrosine kinase receptor expressed on hematopoietic multipotential progenitors and more downstream progenito...

